RA Capital Management

Activity in this selectionEnterprise software

By stage

Series A2

Series B2

Growth1

Undisclosed1

Biotech5

Healthtech1

United States6

6 in this selection

Jul 2

Develops treatments for serious respiratory diseases

$180MGrowth

Role not disclosed

Jun 24

Develops bispecific antibody therapies for retinal vascular diseases including diabetic macular edema and wet AMD

$330MSeries B

Role not disclosed

Jun 23

Develops broad-spectrum antiviral prophylactic therapies for respiratory infections

$34MUndisclosed

Role not disclosed

Jun 2

Develops hormonal and non-hormonal male contraceptives for men and couples globally

$92.5MSeries B

Role not disclosed

May 27

Clinical-stage company developing neonatal cardiac progenitor cell therapies for Duchenne-associated cardiomyopathy

$30MSeries A

Role not disclosed

Mar 5

Provides CAR-T and other advanced treatment delivery in community outpatient settings

$19MSeries A

Role not disclosed